These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 28681913)
1. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913 [TBL] [Abstract][Full Text] [Related]
2. Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein. Sun Y; Liu W; Wang C; Meng Q; Liu Z; Huo X; Yang X; Sun P; Sun H; Ma X; Peng J; Liu K J Cell Physiol; 2019 Apr; 234(4):3685-3696. PubMed ID: 30171603 [TBL] [Abstract][Full Text] [Related]
3. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
4. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615 [No Abstract] [Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
6. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
7. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
8. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines. Meesungnoen J; Jay-Gerin JP; Mankhetkorn S Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Hu Y; Cheng X; Li S; Zhou Y; Wang J; Cheng T; Yang M; Xiong D Cancer Chemother Pharmacol; 2013 Oct; 72(4):789-98. PubMed ID: 24013575 [TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
11. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells. Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993 [TBL] [Abstract][Full Text] [Related]
12. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo. Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924 [TBL] [Abstract][Full Text] [Related]
13. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways. Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511 [TBL] [Abstract][Full Text] [Related]
14. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related]
15. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression. Pan J; Miao D; Chen L Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913 [TBL] [Abstract][Full Text] [Related]
16. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231 [TBL] [Abstract][Full Text] [Related]
17. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells. Chen FY; Cao LF; Wan HX; Zhang MY; Cai JY; Shen LJ; Zhong JH; Zhong H Mol Med Rep; 2015 Jan; 11(1):341-8. PubMed ID: 25339540 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
19. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin]. Li BR; Wang L; Han WN; Xia LQ; Tang S Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359 [TBL] [Abstract][Full Text] [Related]
20. Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1. Wang C; Huo X; Wang L; Meng Q; Liu Z; Liu Q; Sun H; Sun P; Peng J; Liu K Sci Rep; 2016 Jun; 6():28403. PubMed ID: 27329817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]